AbbVie Faces Third Jury In Testosterone MDL
AbbVie will defend its product AndroGel for the third time Monday against claims it seriously injured one of its users as the company takes on the latest bellwether in multidistrict litigation...To view the full article, register now.
Already a subscriber? Click here to view full article